NOVOS develops science-based dietary supplements and a longevity-focused platform intended to slow cellular aging and extend healthspan and lifespan. The company says it is the first to address the nine hallmarks of aging and assembles an advisory and scientific board of noted longevity researchers. NOVOS launched in October 2020 after being founded in 2018 and sells products directly via its website. It emphasizes a data-driven, evidence-based approach and has enlisted prominent scientists to guide product development. The company plans to invest in clinical research and build a leading longevity platform to help consumers navigate the supplement market. Recent financing will support rapid growth and further research efforts.

Total raised

$3M

Funding rounds

1

Latest round

Seed

Latest activity

Oct 2021